Centessa Pharmaceuticals (uk) Limited
Clinical trials sponsored by Centessa Pharmaceuticals (uk) Limited, explained in plain language.
-
Extended trial tests sleep disorder Drug's Long-Term safety
Disease control Recruiting nowThis study continues testing the safety and effectiveness of ORX750 medication for people with narcolepsy or idiopathic hypersomnia who completed an earlier trial. It follows 90 participants to monitor long-term side effects and whether the drug continues to help with daytime sle…
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New brain protein mimic aims to wake up sleep disorder patients
Disease control Recruiting nowThis study is testing a new drug called ORX750 in people with narcolepsy or idiopathic hypersomnia, conditions that cause severe daytime sleepiness. The main goals are to see if the drug is safe and how the body processes it. Researchers also want to find out if it can help peopl…
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug tested to fight daytime sleepiness
Symptom relief Recruiting nowThis is an early-stage study to test the safety of a new drug called ORX142 for people who struggle with excessive daytime sleepiness. Researchers will give the drug to healthy adults, including some who are sleep-deprived, to see how their bodies handle it and if it helps them s…
Phase: PHASE1 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New wakefulness drug begins first human tests
Knowledge-focused Recruiting nowThis is an early-stage study to check the safety of a new oral drug called ORX489 in healthy adults. Researchers will give single and multiple doses to see how the body handles the drug and if it helps people stay awake. The main goal is to understand the drug's side effects and …
Phase: PHASE1 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:26 UTC